The New England journal of medicine

• Latest
• Best
• Search…

• N. Engl. J. Med. · Jun 2023

  Approving Workplace Accommodations for Patients with Long Covid - Advice for Clinicians.

  no abstract available

  expand abstract… mark as read…

• N. Engl. J. Med. · Jun 2023

  Comment Letter

  Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus. Reply.

  no abstract available

  read more… or not…

• N. Engl. J. Med. · Jun 2023

  Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

  no abstract available

  keep reading… mark as read…

• N. Engl. J. Med. · Jun 2023

  Editorial

  Safely Increasing Heart Transplantation with Donation after Cardiac Death.

  no abstract available

  keep reading… or not…

• N. Engl. J. Med. · Jun 2023

  Randomized Controlled Trial

  Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

  Standard first-line chemotherapy for endometrial cancer is paclitaxel plus carboplatin. The benefit of adding pembrolizumab to chemotherapy remains unclear. ⋯ In patients with advanced or recurrent endometrial cancer, the addition of pembrolizumab to standard chemotherapy resulted in significantly longer progression-free survival than with chemotherapy alone. (Funded by the National Cancer Institute and others; NRG-GY018 ClinicalTrials.gov number, NCT03914612.).

  expand abstract… mark as read…